...
首页> 外文期刊>Clinical neurology and neurosurgery >Cardiac responses of vagus nerve stimulation: Intraoperative bradycardia and subsequent chronic stimulation.
【24h】

Cardiac responses of vagus nerve stimulation: Intraoperative bradycardia and subsequent chronic stimulation.

机译:迷走神经刺激的心脏反应:术中心动过缓及随后的慢性刺激。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Few adverse events on heart rate have been reported with vagus nerve stimulation (VNS) for refractory epilepsy. We describe three cases with intraoperative bradycardia during device testing. PATIENTS AND METHODS: At our hospital 111 patients have received a VNS system. Intraoperative device testing is performed under ECG-monitoring. We reviewed the patients and their VNS-therapy follow-up outcome who experienced a change in heart rate, during device testing (Lead Test). RESULTS: Three patients with medically refractory epilepsy showed a bradycardia during intraoperative Lead Test. Postoperative the VNS-therapy started under ECG-monitoring. No change in cardiac rhythm occurred. Subsequent chronic stimulation is uneventful. All three have reduced seizure frequency. Two already have had their second implant, without the occurrence of bradycardia. CONCLUSION: In case of intraoperative bradycardia VNS-therapy onset should be done under ECG-monitoring. Subsequent chronic stimulation is safe in respect to heart rate. Bradycardia during intraoperative device testing is no reason to abort the operation.
机译:目的:迷走神经刺激(VNS)治疗难治性癫痫的心率不良事件很少。我们描述了在设备测试期间术中心动过缓的三例。患者与方法:在我们医院,有111名患者接受了VNS系统。术中设备测试是在ECG监测下进行的。我们回顾了在设备测试(铅测试)期间经历心率变化的患者及其VNS疗法的随访结果。结果:3例难治性癫痫患者在术中铅测试中出现心动过缓。术后VNS治疗在ECG监测下开始。心律没有改变。随后的慢性刺激是平稳的。这三个都降低了癫痫发作频率。其中两个已经进行了第二次植入,没有发生心动过缓。结论:在术中心动过缓的情况下,应在ECG监测下开始VNS治疗。随后的慢性刺激在心率方面是安全的。术中设备测试期间的心动过缓是没有理由中止手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号